---
title: "Revolution Medicines tumbles 10% as biotech sector sells off"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301299588.md"
description: "RVMD tumbled 10% in regular trading as biotech weakness dragged shares lower; LifeSci Capital maintains Buy, $315 PT."
datetime: "2026-10-08T15:40:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301299588.md)
  - [en](https://longbridge.com/en/news/301299588.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301299588.md)
generator: "portal-rs"
---

# Revolution Medicines tumbles 10% as biotech sector sells off

Revolution Medicines(RVMD.US) 盘中跌 10.04%，现报**180.705 美元**。

生物科技板块遭遇普跌，Moderna、Vaxcyte 等个股均遭大幅抛售，RVMD 亦受板块情绪拖累。LifeSci Capital 分析师维持对 RVMD 的买入评级，目标价**315 美元**，认为其 RAS 产品管线动能强劲。公司近期启动针对一线转移性 RAS G12D 胰腺癌的 RASONQUE 与 zoldonrasib 联合用药第三期临床试验，ESMO GI 2026 数据显示其可改善患者生存率。

### Related Stocks

- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)

## Related News & Research

- [What Revolution Medicines Stock's FDA Approval Means For Shareholders](https://longbridge.com/en/news/304477947.md)
- [Revolution Medicines Q3 revenue reaches $198 mln after RASONQUE launch](https://longbridge.com/en/news/304336160.md)
- [Is the Stock Market Going to Crash? Warren Buffett's Warning Is Hard to Ignore.](https://longbridge.com/en/news/305154637.md)
- [US SEC seeks to close Musk, Tesla settlement fund](https://longbridge.com/en/news/305073867.md)
- [Investors Shouldn't Be Too Comfortable With Novo Nordisk's (CPH:NOVO B) Earnings](https://longbridge.com/en/news/305120829.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**